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Background: Astrocytes regulate neuronal excitability and synaptic activity by releasing gliotransmitters such as
glutamate. Our recent study demonstrated that astrocytes release glutamate upon GPCR activation via Ca2+
activated anion channel, Bestrophin-1 (Best1). The target of Best1-mediated astrocytic glutamate has been shown to
be the neuronal NMDA receptors (NMDAR). However, whether it targets synaptically or extra-synaptically localized
NMDAR is not known.
Findings: We recorded spontaneous miniature excitatory postsynaptic currents (mEPSCs) from CA1 pyramidal cells
to test whether Best1-mediated astrocytic glutamate targets synaptic NMDAR. An agonist of protease activated
receptor 1 (PAR1) was used to induce astrocytic Ca2+ increase and glutamate release. Firstly, we found that
activation of PAR1 and subsequent release of glutamate from astrocyte does not alone increase the frequency of
mEPSCs. Secondly, we found that mEPSC rise time is variable depending on the different electrotonic distances
from the somatic recording site to the synaptic region where each mEPSC occurs. Two subgroups of mEPSC from
CA1 pyramidal neuron by rise time were selected and analyzed. One group is fast rising mEPSCs with a rise time of
1 ~ 5 ms, representing synaptic activities arising from proximal dendrites. The other group is slowly rising mEPSCs
with a rise time of 5 ~ 10 ms, representing synaptic events arising from glutamate release at synapses located in the
distal dendrites. We used cell-type specific Best1 gene silencing system by Cre-loxP cleavage to dissociate the effect
of neuronal and astrocytic Best1. Astrocytic Best1-mediated glutamate release by PAR1 activation did not affect
decay kinetics, frequency, and amplitude of fast rising mEPSC. In contrast, PAR1 activation resulted in an NMDA
receptor component to be present on slowly rising mEPSC, but did not alter frequency or amplitude.
Conclusions: Our results indicate that astrocytic glutamate via Best1 channel targets and activates synaptic
NMDARs.
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Astrocytes provide structural scaffolding and nutrients to
neurons as well as a mechanism for removing released neu-
rotransmitters [1]. Recently, several studies have shown that
astrocytes can be activated by sensory stimulation [2] or
several pathological conditions including brain ischemia or
inflammation [1,3-6]. These stimuli evoke increases in
intracellular Ca2+ in astrocytes, which in turn elicit the re-
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reproduction in any medium, provided the orThese released gliotransmitters are known to be involved in
modulating neuronal synaptic plasticity [3,10], synaptic
scaling [7-9], and even excitotoxicity [11]. It has been
reported that astrocytic glutamate is released by multiple
mechanisms. However, we have recently reported that
when Gαq-coupled receptors such as PAR1 are activated,
astrocytes release glutamate via Ca2+ activated anion chan-
nel, Bestrophin1 (Best1) [12].
Bestrophin is the gene linked to Best's vitelliform macu-
lar dystrophy and has been shown to encode a functional
Ca2+-activated anion channel (CAAC) in nonneuronal tis-
sue and peripheral neurons [13]. This Bestrophin-1 chan-
nel (Best1) is directly activated by submicromolar
intracellular Ca2+ concentration and has an anion selective
pore with single channel activities [13-20]. Recently, we. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in astrocytes of the CA1 hippocampus [21], that Best1
channels show unique permeability to large anions and
osmolytes such as GABA and glutamate [12,22], that
Best1 channels are selectively expressed at the astrocytic
microdomains adjacent to glutamatergic synapse by
immunogold electron microscopy [12], and that glutamate
released via Best1 channel activates neuronal NMDA
receptors in hippocampal CA1 pyramidal neurons [12].
However, whether astrocytic glutamate via Best1 channel
targets synaptically localized NMDAR is unknown.
Miniature excitatory postsynaptic currents (mEPSCs)
provide an elegant way to examine the mechanism at
synaptic level because individual mEPSC represents one
quantal release and activation of receptors localized at
one synapse. Under the resting condition with a holding
potential, Vh = −60 mV, the mEPSC kinetics represents
current mediated entirely by synaptically localized
AMPA receptor activation (rise) and desensitization
(decay). The decay of AMPA receptor mediated mEPSCs
can be well fitted to a single exponential decay function.
The presence of normal levels of Mg2+ (1.5 mM) in the
ACSF provides robust voltage dependent channel block
of any synaptic NMDA receptors. However, under cer-
tain circumstances mEPSCs can contain a component by
activation of synaptic NMDA receptor. These circum-
stances include when Mg2+ block of NMDA receptors
has been relieved by either low Mg2+ or depolarization
of the membrane potential of the postsynaptic compart-
ment. The NMDA receptor component usually appears
under voltage clamp as a slow, noisy inward current that
is superimposed on the decay phase of mEPSCs. Under
this condition, the decay of these mixed mEPSCs cannot
be fitted well with a single exponential function, but






















Figure 1 Fast and slowly rising mEPSCs in CA1 pyramidal neuron. A.
time of mEPSCs recorded from CA1 pyramidal neuron. F is fast rising mEPS
mEPSCs recorded from 3 cells for 8 minutes. Fast rise time of mEPSCs is 1 ~
diagram of fast rising and slowly rising mEPSCs. Somatic region of CA1 pyr
(holding potential −60 mV).second of which reflects the time course of synaptic
NMDA receptors.
In the present study, we explored the possibility that
Best1-mediated astrocytic glutamate targets synaptically
localized NMDAR by recording mEPSCs. We also uti-
lized the cell type specific gene silencing system to dis-
sociate astrocytic Best1. We demonstrate that Best1-
mediated astrocytic glutamate by PAR1 activation causes
an appearance of NMDAR component in slowly rising
mEPSC, indicating targeting and activation of synaptic
NMDARs.
Results
Two subgroup of mEPSC from CA1 pyramidal neuron
It has been well established that astrocytically released glu-
tamate preferentially activates NMDAR in neighboring
neurons in voltage- and Mg2+-dependent manner [24-28].
And recently we reported that astrocytically released glu-
tamate via Best1 channel activates neuronal NMDARs in
the hippocampal CA1 pyramidal neurons [12]. To examine
whether Best1-mediated glutamate can activate synaptically
localized neuronal NMDAR, we recorded mEPSCs from
CA1 pyramidal neuron at −60 mV in the presence of tetro-
dotoxin (TTX) and Bicuculline to isolate miniature EPSCs.
We divided mEPSCs into two groups by rise time. Fast ris-
ing mEPSCs with 1 ~ 5 ms rise time could be clearly distin-
guished from slowly rising mEPSCs with 5 ~ 10 ms rise
time (Figure 1A, B). The activation of AMPA receptors at
synapse occurs on a sub-millisecond time scale, whereas
the decay of mEPSCs is much slower, with time constants
typically being 10’s of milliseconds. When these mEPSCs
occur at significant electrotonic-distance from the record-
ing electrode, the rise of mEPSCs can be distorted or fil-
tered by the dendritic compartment, which acts as a series








Fast rise Slow rise
Example traces of mEPSCs from three different slices show different rise
Cs, and s is slowly rising mEPSCs. B. The histogram of rise times of 240
5 ms, and slow rise time of mEPSCs is 5 ~ 10 ms. C. Schematic
amidal neurons is whole cell patched under voltage clamp
Han et al. Molecular Brain 2013, 6:4 Page 3 of 9
http://www.molecularbrain.com/content/6/1/4kinetics [29-31]. Therefore, the mEPSCs from more distant
places display slower rise (Figure 1C). Another important
feature of distal regions of the neuron is that the voltage
control can be incomplete, under voltage clamp.
Astrocytic glutamate does not produce mEPSCs
PAR1-induced astrocytic glutamate release occurs with a
slow time course, on the order of seconds [12]. Therefore,
it is unlikely to cause a current that has the appearance of
an mEPSC with millisecond kinetics, even though Best1 is
expressed at the microdomains of astrocyte near the post-
synaptic membrane. To test the possibility that glutamate
release from astrocytes can itself generate mEPSC, we
recorded under voltage clamp after treating the slices with
Concanamycin A (2 μM, at least 2 hrs) to minimize the
contribution of neuronal glutamate release, making any
potential PAR1-induced mEPSC more readily apparent.
To induce astrocytic glutamate release, we used 30 μM
TFLLR application to activate PAR1, which is known to be
expressed mostly in CA1 hippocampal astrocytes [4,32].
We found that Concanamycin A treatment reduced but
did not completely eliminate mEPSCs (Figure 2A, B). This
is consistent with the previous report that Concanamycin
A treatment without neuronal activity was not able to
completely deplete glutamate from presynaptic vesicles





















Figure 2 PAR1 activation does not generate mEPSCs. A. Hippocampal
minimize presynaptic glutamate release. The representative traces indicate
treatment and after treatment, respectively. Asterisk shows mEPSCs. Right :
graphs represent the averaged amplitudes and frequencies of mEPSCs. Num
indicated in the bar graph. P-value : 0.216 (amplitude), 0.853 (frequency).[33]. Under this condition, the induction of glutamate re-
lease from astrocytes by TFLLR did not significantly alter
the frequency or the peak amplitude of mEPSCs, indicat-
ing that astrocytic glutamate release does not generate
mEPSCs (Figure 2B).
Best1-mediated astrocytic glutamate did not affect fast
rising mEPSCs
We previously demonstrated that TFLLR-induced astro-
cytic glutamate affects mEPSC decay kinetics by reveal-
ing an APV-sensitive component of the decay in slowly
rising miniature EPSC (mEPSC) recorded from CA1 pyr-
amidal neuron, secondary to postsynaptic depolarization
and relief of Mg2+ block at poorly clamped distal synapses
[24]. To test whether Best1 channels expressed in astro-
cytes are responsible for inducing this NMDAR component
of decay in mEPSC, we used a molecular genetic strategy
utilizing the Cre-loxP conditional gene silencing system to
selectively silence the target gene in the desired cell type
[22,34]. To isolate the effect of astrocytic Best1, we used
hGFAP-CreERT2 mice regulated by tamoxifen and lenti-
viral loxP-floxed Best1 shRNA. In this mouse, the CreERT2
is expressed under the control of the GFAP promoter [35].
Best1 shRNA is expressed both in neurons and astrocytes
in the absence of tamoxifen, whereas, Best1 shRNA cassette


















slices were pretreated with concanamycin A (2 μM ; ~2 hr) to
mEPSCs from the concanmycin A pretreated slices before TFLLR
expanded mEPSC traces from basal or TFLLR-treated slices. B. Bar
bers of tested slices from at least two independent mice are
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the effect of Best1 expression in CA1 neurons, we used
Ca2+/calmodulin-dependent kinase IIα promoter-driven
Cre expressing (CaMKIIα-Cre) mice [36] and lentiviral
loxP-floxed Best1 shRNA. Under this condition, Best1
shRNA is expressed in all cells, except in CA1 pyramidal
neurons. Using cell-type specific Best1 gene silencing sys-
tem we recorded mEPSCs in CA1 pyramidal neuron.
Fast rising mEPSCs with a rise time of 1 ~ 5 ms were
scaled, averaged, and fitted with a sum of two exponen-
tial functions. If the difference between the first decay
constant (tau 1) and the second decay constant (tau 2)
was less than 10% of the average tau 2 value, the curve
was subsequently refitted with a single exponential func-
tion [24] (Figure 3A, B). In this case, tau 1 and tau 2 of
fast rising mEPSCs by two exponential functions are
almost same, because activation of NMDARs is not
detected in fast rising mEPSCs occurring in proximal
synapse with adequate voltage control (Figure 3B). To
assess fit quality, we analyzed traces with the coefficient
of determination, R2 value above 0.9. If R2 value was less
than 0.9, we did not include in analysis. The difference
between tau 1 and tau 2 of fast rising mEPSCs was
mostly within 10%. Therefore, we refitted those with a
single exponential function (Figure 3A) and measured
decay tau (Figure 3C). The decay tau of fast rising































Figure 3 Decay kinetics of fast rising mEPSCs was not changed by PA
mEPSC traces (gray) from fast rising mEPSCs in scrambled shRNA or Best1 s
green), TFLLR treated group (TFLLR; red), and TFLLR + APV-treated group (A
function. B. Example of decay fitting by a single exponential function. Fast
by a single component exponential function. Red line indicates decay fittin
detected in fast rising mEPSCs. C. Bar graphs represent single component o
(red), and after TFLLR + APV (blue) treatment in naïve, scrambled shRNA inj
injected CaMKIIα-Cre mice, respectively. Sc, scrambled shRNA. B1, Best1 shR
independent mice are indicated.astrocytic glutamate, suggesting that activation of synaptic
NMDARs by Best1-mediated astrocytic glutamate did not
appear in fast rising mEPSCs (Figure 3C). Frequency and
peak amplitude of fast rising mEPSCs were not affected by
Best1-mediated astrocytic glutamate (Figure 4A, B).
Best1-mediated astrocytic glutamate causes an
appearance NMDAR component in slowly rising mEPSCs
without affecting frequency and amplitude
Next, slowly rising mEPSCs with a rise time of 5 ~ 10 ms
were scaled, averaged, and fitted with a sum of two ex-
ponential functions (Figure 5A). The difference between
tau 1 and tau 2 of slowly rising mEPSCs was more than
10%. We measured both fast component of decay tau
(tau 1) and slow component of decay tau (tau 2) of
slowly rising mEPSCs (Figure 5B). Fast component of
decay tau (tau 1) was not changed by Best1-mediated
astrocytic glutamate (Figure 5C). We found that in both
naïve and scrambled-shRNA slices, PAR-1 activation eli-
cited an appearance of the NMDAR component, mea-
sured as the decay time constant (tau 2) of 2-component
exponential decay function model (Figure 5D). The ap-
pearance of tau 2 was no longer observed in Best1-
shRNA expressing slices from hGFAP-CreERT2 mice
without tamoxifen treatment or CaMKIIα-Cre mice
(Figure 5D). The disappearance of tau 2 by Best1 gene













B Without NMDAR component
R1 activation. A. Representative superimposed, normalized, averaged
hRNA infected slices. The average traces from basal condition (Before;
PV; blue) were best fitted with a single component exponential
rising mEPSCs from TFLLR treated hippocampal slices was fitted well
g by a single exponential decay function. NMDAR component is not
f decay tau of fast rising mEPSCs before TFLLR (green), after TFLLR
ected naïve, Best1 shRNA injected hGFAP-CreERT2, or Best1 shRNA



































































Figure 4 Frequency and amplitude of fast rising mEPSCs were not changed by PAR1 activation. A, B) Summary of frequency (A) and
amplitude (B) of fast rising mEPSCs in naïve, scrambled shRNA injected naïve, Best1 shRNA injected hGFAP-CreERT2, or Best1 shRNA injected
CaMKIIα-Cre mice, respectively. Both frequency and amplitude were not significantly changed by TFLLR treatment. N indicates the number of
tested slices at least three different mice.
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These results suggest that Best1-mediated glutamate from
astrocyte targets synaptic NMDAR located in distal synap-
ses which display slowly rising mEPSCs because of poor
voltage control (Figure 5E). Best1-mediated glutamate re-
lease from astrocyte did not affect either the frequency or
peak amplitude of slowly rising mEPSCs (Figure 6A, B).
These results indicate that Best1 channels expressed in
astrocytes are responsible for the appearance of NMDAR
component in decay of mEPSCs, and indicate that Best1-
mediated glutamate release from astrocytes can target syn-
aptically localized NMDARs.
Discussion
The important finding of this study is that astrocytically
released glutamate via Best1 targets and activates synap-
tically localized NMDARs in hippocampal formation.
In addition, we demonstrated that the appearance of
NMDAR component in the decay of AMPAR-mediated
mEPSC occurred in a specific population of mEPSCs
that originated from distal dendrites rather than prox-
imal dendrites; these mEPSCs slowly rose due to the
dendritic RC filtering, which we used as a marker for
distal mEPSCs.
The distance from the recording electrode also affects
the ability to voltage clamp under voltage clamp config-
uration by the virtue of space clamp problem. The distalsynapses can be less well clamped and can easily escape
from voltage clamping under depolarizing stimulus,
whereas proximal synapses can be better voltage clamped.
When there is a depolarizing condition such as astrocytic
glutamate release that leads to depolarization of distal
synapses due to extrasynaptic NMDA receptor activation,
membrane voltage can escape from voltage clamp and
allow the synaptic NMDA receptors to relieve the Mg2+
block. This phenomenon becomes more pronounced when
there is a co-incidence of presynaptic quantal release to ac-
tivate synaptic AMPA receptors to cause a depolarization
to instantly relieve the Mg2+ block of NMDA receptors
during a mEPSC. Therefore, due to space clamp problem,
the mEPSCs occurring at distal synapses show pronounced
NMDA receptor component of the mEPSCs as evidenced
by the appearance of 2nd exponential decay component in
the decay phase of mEPSCs.
In our previous paper, we have demonstrated that
TFLLR activation of PAR1 causes astrocytic glutamate
release and this release can be detected as an appearance
of the NMDAR component in the decay of mEPSCs, as
evidenced by the presence of 2nd exponential function in
the decay fitting [24]. The appearance of APV-sensitive
NMDAR mediated slow component that rides on top of
the decay kinetics of AMPA receptor component of
mEPSCs is induced by TFLLR application only in
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B With NMDAR component
N.D. N.D. N.D. N.D. N.D. N.D. N.D.
E
Vm = -60 mV
Vh = -60 mV
Vm = ~-50 mV








Vm = -60 mV Vm = -60 mV
Figure 5 An appearance of NMDAR component in slowly rising mEPSCs by PAR1 activation. A. Representative superimposed, normalized,
averaged mEPSC traces (gray) from slowly rising mEPSCs in scrambled shRNA or Best1 shRNA infected slices. The average traces from basal
condition (left, Before; green) and TFLLR + APV treated group (APV; blue) were best fitted with a single component exponential function. But
mEPSC traces from TFLLR-treated group (TFLLR; red) were best fitted with a two component exponential function, which is impaired by Best1
shRNA expression (right). B. Example of decay fitting by two component exponential functions in TFLLR treated slices. Red line is decay fitting by
single exponential function, and blue line is decay fitting by second exponential decay function. NMDAR component is detected in slowly rising
mEPSCs generated in distal dendrite. C. Bar graphs represent fast component of decay tau of slowly rising mEPSCs. Tau 1 was not significantly
changed by Best1-mediated astrocytic glutamate. D. Summary of slow component of decay tau of slowly rising mEPSCs. N.D. indicates not
detected by a two exponential function fitting. E. Schematic diagram of fast rising and slowly rising mEPSCs in the presence of TFLLR. NMDAR
component is not detected in fast rising mEPSCs generating at the proximal dendrites clamped well, whereas activation of NMDAR by TFLLR can
be detected at the distal dendrites because of poor voltage clamp.
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drites. Synaptic NMDAR acts as a coincidence detector
when there is a coincidental depolarization by synaptic
AMPAR and this feature originates from the ability to
relieve the Mg2+ block. This is due to the incompletevoltage clamp in distal dendrites that allows voltage es-
cape and subsequent relief from the Mg2+ block of syn-
aptic NMDA receptors.
All mEPSCs, slowly rising or fast rising mEPSCs, ori-
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Figure 6 Frequency and amplitude of slowly rising mEPSCs were not changed by PAR1 activation. A, B) Summary of frequency (A) and
amplitude (B) of fast rising mEPSCs in respective mice. Both frequency and amplitude were not significantly changed by PAR1 activation.
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ectly monitor what goes on at individual synapse, which
contains both AMPAR and NMDAR. Under normal
condition both slowly rising and fast rising mEPSCs
recorded under voltage clamp only display AMPAR
mediated component, with no apparent NMDAR com-
ponent due to strong Mg2+ block at holding potential
of −60 mV or so (Figure 5D, E). When there is TFLLR-
induced glutamate release from astrocytes close to or at
the synapse, the astrocytic glutamate does not produce
an “mEPSC-like” waveform, but instead diffuses slowly
at low concentration (1 uM), binds to and activating
NMDAR slowly. We propose that continued activation
at low level of NMDA receptors (likely receptors with
reduced Mg2+ sensitivity, including NR2D or NR3 subu-
nits) can produce a small inward current that will
depolarize distal dendritic spines. Normally NMDAR are
under strong Mg2+ block. However, with the tonic low
level of NMDA receptor activation following astrocytic
release of glutamate, there will be a reduction on voltage
dependent Mg2+ block such that release of glutamate
from presynaptic terminal, will activate the synaptic
NMDARs and this opening shows up in the decay phase
of mEPSC. This is only possible when voltage can escape
from the holding voltage during the synaptic release of
glutamate. This voltage escape is pronounced (and de-
tectable) in the distal synapses where voltage clamping is
hard to achieve. Therefore, the fast rising (well-clamped)
mEPSCs do not show this NMDAR component byTFLLR, whereas the slowly rising (poorly clamped) distal
synapses do show the NMDA receptor component.
It is important to note that even though the fast rising
mEPSCs do not show NMDAR component upon TFLLR
application, this does not necessarily mean that astro-
cytic glutamate release via Best1 channels is absent in
the proximally located synapses. The reason the NMDAR
component is not prominent in fast rising mEPSCs is
because the proximal dendrites are well-clamped under
voltage clamp configuration. However, under the nat-
ural condition where membrane voltage is free to
change, it is expected that distal as well as proximal
synaptic events are equally affected by astrocytic glu-
tamate release via Best1 channel. Therefore, astrocytic
glutamate release should globally affect the synaptic
NMDAR, regardless of the location of synapses along a
dendrite.
Best1-mediated glutamate from astrocyte targets
NMDARs not AMPARs. In our recent study, we calcu-
lated the concentration of glutamate released by astro-
cyte via Best1 channel. The concentration of Best1
mediated glutamate release is around 1 μM [12]. This
concentration is just enough to activate NMDA recep-
tors (EC50: ~ 3 μM) but not sufficient to activate AMPA
receptors (EC50: ~ 1000 μM). In addition, AMPA recep-
tors are highly desensitizing, and the decay kinetics of
mEPSCs is strongly influenced by the desensitizing kin-
etics of the AMPA receptors. Nevertheless, there is a
possibility that 1 μM glutamate can activate synaptic
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ent due to strong desensitization.
It is also worthwhile to note that whether the glutam-
ate released by Best1 channel binds directly to synaptic-
ally localized NMDAR or not is still not clear.
Considering the fact that Best1 channel is specifically
localized at the microdomains of astrocytes near synap-
tic junctions [12], one can predict that glutamate released
by Best1 channel should directly activate the synaptically
localized NMDARs at the post synapse. On the other
hand, it is equally possible that astrocytic glutamate can
activate extra-synaptic NMDARs and then subsequently
affect the synaptic NMDARs. In this study, we could not
distinguish the two possibilities. For future studies, it will
be interesting to test the effect of activity-dependent pore
block of synaptic NMDARs using the MK-801 to distin-
guish the two possibilites.
In summary, we demonstrated that the TFLLR-induced
appearance of NMDAR-mediated, slow component of
mEPSC in the subpopulation of slowly rising mEPSCs is
due to astrocytic glutamate release through Best1 channels
that specifically target the synaptically localized NMDAR.
Methods
Delivery of lentiviral vector containing Best1 shRNA into
mouse hippocampus
hGFAP-CreERT2 transgenic mice was provided by Dr. Ken
McCarthy. CaMKIIα-Cre transgenic mice were purchased
from Jackson Laboratory. hGFAP-CreERT2 mice were used
at the age of 7 weeks for tamoxifen or sun flower oil injec-
tion (intraperitoneal injection, once per day for 5 days).
Then the lentivirus carrying Best1 shRNA was injected
1 day after 5th day injection. Finally the mice were sacrificed
for mEPSC recordings at 7 ~ 9 weeks of age. CaMKIIα-Cre
was used at 7 ~ 8 weeks of age for virus injection and used
at around 9 weeks for electrophysiological recordings. Only
male mice were used in this study.
Slice preparation
Adult mice (7 ~ 9 weeks) were deeply anaesthetized until
cessation of breathing and subsequently decapitated.
The brain was rapidly removed and submerged in an
ice-cold oxygenated artificial cerebrospinal fluid (ACSF)
composed of (in mM) 130 NaCl, 24 NaHCO3, 3.5 KCl,
1.25 NaH2PO4, 1 CaCl2, 3 MgCl2, 10 glucose at pH 7.4,
and was bubbled with 5% CO2 / 95% O2. Transverse
mouse brain slices (350 ~ 400 μm) containing hippocam-
pus were acutely prepared with a Leica vibratome (Leica
VT1000S), and incubated in a chamber with oxygenated
ACSF at room temperature for 1 hr before use.
Recording of mEPSCs
The standard ACSF recording solution was composed of
(mM): 130 NaCl, 24 NaHCO3, 3.5 KCl, 1.25 NaH2PO4,1.5 CaCl2, 1.5 MgCl2 and 10 glucose saturated with 95%
O2–5% CO2, at pH 7.4. The internal solution was com-
posed of (mM): 140 Cs-MeSO4, 10 Hepes, 7 NaCl, 4 Mg-
ATP and 0.3 Na3-GTP. Visually guided whole-cell patch
recordings were obtained from CA1 pyramidal neurons.
Recordings were obtained using Axopatch 200A (Axon
instruments, Union City, CA, USA) and filtered at 2 kHz.
In case of mEPSC recording, recordings were digitized at
10 kHz, and analyzed using pCLAMP 9 (Molecular
devices) and Mini Analysis Program (Synaptosoft) as pre-
viously described [24]. The mEPSCs were automatically
detected and grouped as fast (1–5 ms) and slow rise time
(5–10 ms). All experimental procedures described were
performed in accordance with the institutional guidelines
of Korea Institute of Science and Technology (KIST,
Seoul, Korea).
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